← All Cloopen Group Holding LTD filings

Cloopen Group Holding LTD 20-F annual reports

The annual report filed by foreign private issuers listed on a US exchange — the 10-K’s equivalent for non-US companies.

OTC.Pink
RAASY
Cloopen Group Holding LTD
20-F: Cloopen Group Faces Declining Revenue, Mounting Losses in 2025
Cloopen Group Holding Limited reported a 6.6% revenue decrease and a 62.6% increase in net loss for 2025, alongside ongoing internal control weaknesses and a pending going-private proposal.
OTC.Pink
RAASY
Cloopen Group Holding LTD
20-F: Cloopen Reduces Losses Amidst Flat Revenue, NYSE Delisting
Cloopen Group Holding Limited reported a significant reduction in net loss for 2024, alongside minimal revenue growth, as it navigates operational challenges and addresses past regulatory issues.
OTC.Pink
RAASY
Cloopen Group Holding LTD
20-F: Cloopen Group Holding Limited Files 2023 Annual Report on Form 20-F
Cloopen Group Holding Limited releases its 2023 annual report, detailing financial performance and key business activities.
OTC.Pink
RAASY
Cloopen Group Holding LTD
20-F: Cloopen Group Holding Limited Files Form 20-F for Fiscal Year Ended December 31, 2022
Cloopen Group Holding Limited's Form 20-F filing details the company's financial performance and operational structure for the fiscal year ended December 31, 2022, highlighting key aspects of its business in the Chinese market.
OTC.Pink
RAASY
Cloopen Group Holding LTD
20-F: Cloopen Group Navigates Contractual Termination Amidst Regulatory Scrutiny
Cloopen Group terminates key contractual agreements with Anxun Guantong, HongShan Shengde, and Ronglian Yitong, signaling a strategic shift amid evolving regulatory landscape.